Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Special report
: The Fierce 50 of 2024
Samsung Group
Asia
Samsung-Biogen, Novartis-BeiGene and more—Fierce Pharma Asia
Samsung Biologics denies rumor of its group's interest in Biogen. Aduhelm gets no-go in Japan. Novartis signs on BeiGene's TIGIT med.
Angus Liu
Jan 7, 2022 9:05am
Biogen shares jump on $42 billion Samsung buyout reports
Dec 29, 2021 3:08pm
Samsung, Moderna, Brii and more—Fierce Pharma Asia
Aug 27, 2021 9:20am
Samsung is pumping billions into its biopharma business
Aug 24, 2021 9:11am
Samsung BioLogics breached accounting laws, agency says
Jul 12, 2018 10:35am
